Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Vivien A. Warren"'
Autor:
Nina Jochnowitz, Catherine Abbadie, Clare London, Gregory J. Kaczorowski, Joseph L. Duffy, Birgit T. Priest, Erin McGowan, Kathryn A. Lyons, Maria L. Garcia, Vivien A. Warren, Xiaohua Li, Bindhu V. Karanam, Scott B. Hoyt, Brande Thomas-Fowlkes, John P. Felix, McHardy M. Smith
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:3640-3645
A series of benzazepinones were synthesized and evaluated for block of Nav1.7 sodium channels. Compound 30 from this series displayed potent channel block, good selectivity versus other targets, and dose-dependent oral efficacy in a rat model of neur
Autor:
Stephen P. Arneric, Vivien A. Warren, Joseph L. Duffy, Owen B. McManus, James B Herrington, Clare London, Terrance P. Snutch, Rodolfo Haedo, Randal M. Bugianesi, Gregory J. Kaczorowski, Ge Dai, Cyrus Eduljee, Scott B. Hoyt, David Parker, McHardy M. Smith, Andrew M. Swensen, Kevin S. Ratliff
Publikováno v:
Molecular Pharmacology. 81:488-497
Biological, genetic, and clinical evidence provide validation for N-type calcium channels (Ca V 2.2) as therapeutic targets for chronic pain. A state-dependent Ca V 2.2 inhibitor may provide an improved therapeutic window over ziconotide, the peptidy
Autor:
Brande S. Williams, Mathew J. Wyvratt, Sriram Tyagarajan, Vivien A. Warren, Catherine Abbadie, Brett Taylor, William J. Martin, Xiaohua Li, William H. Parsons, Nina Jochnowitz, Erin McGowan, Sanjeev Kumar, Ann E. Weber, Gregory J. Kaczorowski, Michael H. Fisher, Bishan Zhou, John P. Felix, Tracy Klatt, McHardy M. Smith, Birgit T. Priest, Prasun K. Chakravarty, Kathryn A. Lyons, Joseph L. Duffy, Ronsar Eid, Maria L. Garcia, Richard M. Brochu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 20:7479-7482
A series of novel biphenyl pyrazole dicarboxamides were identified as potential sodium channel blockers for treatment of neuropathic pain. Compound 20 had outstanding efficacy in the Chung rat spinal nerve ligation (SNL) model of neuropathic pain.
Autor:
James B Herrington, Brande S. Williams, Vivien A. Warren, Rodolfo Haedo, Annie Liang, Cyrus Eduljee, D. Euan MacIntyre, Terrance P. Snutch, Clare London, Randal M. Bugianesi, Shruti Mistry, Owen B. McManus, Gregory J. Kaczorowski, Scott B. Hoyt, McHardy M. Smith, Catherine Abbadie, Kathryn A. Lyons, Elizabeth Tringham, Ge Dai, Joseph L. Duffy, Patricia B. Bunting, Andrew M. Swensen, Sylvia Volksdorf, Valerie V. White, Stephen P. Arneric, Shu-Yu Sun, Nina Jochnowitz, Erin McGowan
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 334:545-555
Voltage-gated calcium channel (Ca(v))2.2 (N-type calcium channels) are key components in nociceptive transmission pathways. Ziconotide, a state-independent peptide inhibitor of Ca(v)2.2 channels, is efficacious in treating refractory pain but exhibit
Autor:
Alison Rush, James B Herrington, Rodolfo Haedo, Mark E. Williams, Owen B. McManus, McHardy M. Smith, Andrew M. Swensen, Ge Dai, Kevin S. Ratliff, Randal M. Bugianesi, Vivien A. Warren
Publikováno v:
ASSAY and Drug Development Technologies. 6:195-212
Cav2.2 channels play a critical role in pain signaling by controlling synaptic transmission between dorsal root ganglion neurons and dorsal horn neurons. The Cav2.2-selective peptide blocker ziconotide (Prialt, Elan Pharmaceuticals, Dublin, Ireland)
Autor:
Matthew J. Wyvratt, Vivien A. Warren, John P. Felix, Maria L. Garcia, Scott B. Hoyt, William H. Parsons, Kathryn A. Lyons, Xiaohua Li, Michael H. Fisher, Clare London, McHardy M. Smith, Birgit T. Priest, Gregory J. Kaczorowski, Doreen E. Cashen, William J. Martin, D. Euan MacIntyre, Brande S. Williams
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:1963-1966
A series of 3-amino-1,5-benzodiazepinones were synthesized and evaluated as potential sodium channel blockers in a functional, membrane potential-based assay. One member of this series displayed subnanomolar, state-dependent sodium channel block, and
Autor:
Charles J. Cohen, Margaret Z Chou, Brande S. Williams, Yui S. Tang, Ivy E. Dick, Brita S. Reiseter, Maria L. Garcia, Gregory J. Kaczorowski, Keith A. Wafford, William J. Martin, Samantha Clark, Vivien A. Warren, Peter T. Meinke, Ge Dai, William H. Parsons, Richard E. Middleton, William A. Schmalhofer, Martin Köhler, McHardy M. Smith, Richard M. Brochu, Shao Pengcheng Patrick, Chou J. Liu, Birgit T. Priest, John P. Felix
Publikováno v:
Biochemistry. 43:9866-9876
Sodium channel blockers are used clinically to treat a number of neuropathic pain conditions, but more potent and selective agents should improve on the therapeutic index of currently used drugs. In a high-throughput functional assay, a novel sodium
Autor:
Vivien A. Warren, Peter T. Meinke, Susan P. Rohrer, Brian R. Petuch, James M. Schaeffer, Gregory J. Kaczorowski, Dennis M. Schmatz, Brande S. Thomas, Eric A. Ertel, Richard M. Brochu, Charles J. Cohen, McHardy M. Smith, Yui Sing Tang
Publikováno v:
Biochemistry. 39:5543-5554
Nodulisporic acid (NA) is an indole diterpene fungal product with insecticidal activity. NA activates a glutamate-gated chloride channel (GluCl) in grasshopper neurons and potentiates channel opening by glutamate. The endectocide ivermectin (IVM) ind
Autor:
Lois K. Miller, Vivien A. Warren, Jeffrey W. Warmke, McHardy M. Smith, Victor M. Garsky, Grigori G. Prikhod'ko, Charles J. Cohen, Holly J.R. Popham, Thomas J. Felcetto, Dan A. Ostlind
Publikováno v:
Biological Control. 12:66-78
Previously, we have described the properties of recombinant baculoviruses expressing three chimeric genes, mag4, sat2, and ssh1, that encode secretable insect selective sodium channel toxins, μ-Aga-IV from the spider Agelenopsis aperta, As II from t
Autor:
Catherine Abbadie, Vivien A. Warren, Xiaohua Li, James B Herrington, Gregory J. Kaczorowski, Shruti Mistry, Feng Ye, Andrew M. Swensen, Prasun K. Chakravarty, Rodolfo Haedo, Kathryn A. Lyons, Owen B. McManus, Randal M. Bugianesi, Mitchell D. Green, Shao Pengcheng Patrick, Maria L. Garcia, Shu-Yu Sun, McHardy M. Smith, Erin McGowan, Nina Jochnowitz, Joseph L. Duffy, Ge Dai
We report the investigation of sulfonamide-derived Cav2.2 inhibitors to address drug-metabolism liabilities with this lead class of analgesics. Modification of the benzamide substituent provided improvements in both potency and selectivity. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a14af3d556993551af77251b7d66937
https://europepmc.org/articles/PMC4027232/
https://europepmc.org/articles/PMC4027232/